Ireland
--:--IST
Active, not recruiting Not applicable

Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life

NCT02839291 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2016-06-14
Last updated
2024-12-27

Condition(s) studied

Tumor With Bone Metastasis

Investigational drug(s) / intervention(s)

quality of life questionariesintravenous or oral bone antiresorptive treatments

Study summary

To evaluate the current medical practice and its influence on health-related quality of life, in patients who are treated with injectable bone antiresorptive drugs (biphosphonates or denosumab) for at least one year.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient with histologically proven tumor with bone metastasis, single or multiple (with or without metastasis extra-osseous) * Patients treated with injectable bone antiresorptive therapy for 12 months or more * Signed written informed consent Exclusion Criteria: * patient with any medical or psychiatric condition or disease which would make the patient inappropriate to complete quality of life questionaries * patient under guardianship, curator or under the protection of justice, pregnant or breast-feeding women

Primary outcome measure(s)

  • evaluation of 4 targeted dimensions of the EORTC-QLQ-BM22 quality of life questionarie — to 6 months
    evaluation of 4 parameters: painful sites characteristics of pain, functional impairment, psychosocial aspect

Trial sites (2)

FacilityCityRegionStatus
Centre Hospitalier Régional Universitaire de Besançon Besançon France
Hôpital Nord Franche-Comté Montbéliard France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02839291 on ClinicalTrials.gov ↗ ← All trials in France